Centeno, Christopher J.
Ghattas, James R.
Dodson, Ehren
Steinmetz, Neven J.
Murphy, Matthew B.
Berger, Dustin R.
Article History
Received: 30 October 2024
Accepted: 24 February 2025
First Online: 28 February 2025
Declarations
:
: This study was self-funded by the Centeno-Schultz Clinic and Regenexx. One or more of the authors has declared a potential conflict of interest. D.B., E.D., M.M., and N.S. are or were employed by Regenexx during the study period but have no further disclosures. C.C. is a shareholder, patent holder, and Chief Medical Officer of Regenexx and an owner of the Centeno-Schultz Clinic. J.G. is a Regenexx provider.